New Name for PCOS Aims to Better Reflect Whole-Body Nature of Condition

Health experts in Jersey are advocating for a shift in terminology to better capture the systemic nature of a condition that impacts over 170 million women worldwide. Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS). The International PCOS Network introduced this change on May 12, aiming to enhance public comprehension and facilitate more effective diagnosis and treatment protocols.

Jessica Pinel, chair of PCOS Jersey and a qualified nutritionist, argues that the previous acronym was misleading. Diagnosed three years ago after incurring over £3,000 in treatment costs, Pinel believes the term PCOS incorrectly confines the disorder to the ovaries. In reality, she emphasizes, it is a comprehensive whole-body condition.

"PCOS limited the condition to having an effect on women's ovaries, whereas we know that it is a full-body condition," Pinel stated. Drawing from her work supporting numerous individuals with the condition, she highlighted the wide spectrum of symptoms that significantly disrupt daily life. These can include fatigue, unwanted hair growth, acne, brain fog, irregular menstruation, and infertility.

Pinel expressed hope that the rebranding will encourage more women to access appropriate support for this diverse range of symptoms, acknowledging that the condition manifests uniquely in each individual. However, she cautioned against relying on social media for medical guidance, citing the prevalence of misinformation on platforms like TikTok, Instagram, and Facebook. She noted that in 2024, the BBC exposed influencers selling fraudulent cures for PCOS. Consequently, Pinel advises seeking professional support and emphasizes the right to a second opinion.

"I wasn't diagnosed the first few times. I had those exploratory tests, so I sought out a secondary opinion because I know my body," she explained. "If you feel like you're not being seen or heard, then please go and seek that second opinion because you deserve it."

Dr. Jessica Langtree-Marsh, a Jersey GP, described PCOS/PMOS as "hugely under-researched and hugely misunderstood." She stressed that early diagnosis and education are critical to ensuring individuals receive the correct assessment. Dr. Langtree-Marsh criticized the historical tendency to overlook the condition until fertility issues arise.

"We see it as just simply: 'Come back when you want to have a baby and we'll fix it then.' Actually, we need to look at this as a lifespan condition," she said. She hopes the new name will promote broader treatment approaches, moving beyond the reliance on contraceptive pills toward metabolic medications that address the underlying systemic issues.

The original condition was identified 70 years ago by surgeons Dr. Irving Stein and Dr. Michael Leventhal, who observed specific ovarian characteristics in women experiencing amenorrhea. It was initially termed Stein-Leventhal Syndrome before being renamed PCOS. Dr. Langtree-Marsh noted that the old name reinforced the misconception that the disorder was localized to the ovaries.

"So the rebranded PMOS is trying to appreciate that it affects women more generally rather than just the ovaries, so that it's a whole body condition," she said. While acknowledging that the new name is somewhat cumbersome, she remains positive about the shift in definition.

The NHS notes that individuals with the condition often exhibit elevated male hormone levels and may experience weight gain and menstrual irregularities. Meanwhile, the Jersey government has confirmed that a women’s health strategy, mandated by the Government Plan, is scheduled for release later this year.

Source: BBC News Generated at: 2026-05-26 05:27:03 UTC